PER 2.44% 8.0¢ percheron therapeutics limited

ta ... waiting for strength, page-7

  1. 13,162 Posts.
    lightbulb Created with Sketch. 1383
    Hot of the press!!!..key words "personalized cancer medicine"...ISIS has always stated that this is the future and ANP has 3 drugs that share ISIS views...



    Foundation Medicine is dedicated to improving cancer care through the development of comprehensive cancer diagnostics that will help physicians inform treatment decisions based on an individual patient's molecular cancer subtype. Foundation Medicine's first laboratory developed test, based on a next-generation sequencing platform, is designed to accommodate a broad landscape of cancer genome information and a growing repertoire of targeted treatments and clinical research opportunities. Foundation Medicine's test will assist physicians to make prompt and informed determinations about the best cancer treatments and clinical trial options for each patient, taking into account each patient's unique cancer-associated alterations alongside publicly available scientific and medical information. The company's founding advisors are world leaders in genome technology, cancer biology and medical oncology; they, alongside clinicians, biotech and molecular diagnostics industry leaders, are working to harness emerging technologies to develop unparalleled tests that will identify and interpret an ever-growing set of actionable genomic alterations, truly enabling personalized cancer medicine.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.002(2.44%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.3¢ 8.4¢ 8.0¢ $58.49K 703.3K

Buyers (Bids)

No. Vol. Price($)
2 127624 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 25545 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.